Global Femtech Overview: Industry Trends, Growth Drivers & Future Outlook

Women's healthcare is undergoing a digital transformation through the rapid growth of the global femtech industry. Explore this comprehensive guide to understand what femtech is, the key factors driving its growth, femtech’s biggest challenges, the role of AI in advancing women's healthcare, and the future outlook for the global femtech market.

Women’s health has often been treated as an afterthought by global healthcare services. For a demographic that forms nearly half of the world’s population, women receive the short end of the stick in terms of dedicated healthcare services and facilities. This gap gave rise to a subsection of the healthcare sector, which focuses solely on women’s health needs.

Referred to as femtech (female technology), this recently popularised sector refers to software, diagnostics, products, and medical devices that use technology to address and support women's health. The term was coined in 2016 by Ida Tin, the founder of the period-tracking app Clue.

Over time, femtech has emerged as one of the fastest-growing and most structurally significant sectors within the global digital health industry. Femtech has gradually grown from niche menstrual tracking tools to a multi-layered healthcare ecosystem, including fertility technology, menopause care, maternal health systems, hormonal diagnostics, and AI-powered predictive medicine.

The global femtech sector is currently valued at $39.3 billion in 2024 (Grand View Research) and is forecast to hit $97.3 billion by 2030, with a 16.4% CAGR, indicating a swift reorientation towards technology-enabled women's healthcare services.

Factors Leading to a Growing Need for Femtech: The Clinical Gap

The rapid growth of femtech as an industry has been a result of the grave disparity persistent in global healthcare investments. Women's health receives only 6% of private healthcare funding all over the world (World Economic Forum), although women make up nearly half of the world's population. Women also bear the greater burden of unrecognized and less-studied diseases.

Femtech is rooted in the existing gap in the diagnosis and treatment of women’s health disorders. One of the disorders that has become commonplace for millions of women around the world is endometriosis. It impacts approximately 190 million women globally. Despite its common occurrence, endometriosis usually takes seven to ten years to diagnose due to the system’s inability to diagnose it earlier.

In the same way, PCOS is a condition affecting up to 8–13% of women across the globe (WHO). Notwithstanding, inconsistent screening procedures keep delaying the proper identification and treatment of this widespread condition.

Infertility further increases the importance of innovative solutions. According to the WHO, about one out of six adults suffers from infertility during their lifetime.

In addition to reproductive health, menopause is one of the largest demographic transitions. By 2030, demographic pressures on the healthcare system will be even more exacerbated, as around 1.2 billion women will go through menopause or post-menopause stages, which will probably be one of the biggest healthcare transitions in history. This transition will lead to a growing need for women’s hormonal support, cardiovascular health measures, cognitive health measures, and bone density management.

It’s important to note that femtech is not simply a consumer trend but rather an essential revolution in the way women's healthcare is being provided to meet the needs of the most underserved demographic.

Global Femtech Market Redefining the Boundaries of Digital Health

Femtech Market Size and Expansion: The femtech industry is continually growing. What was initially solely focused on women’s reproductive health has today grown to address a plethora of women’s health and wellness needs. Femtech’s core valuation stands at $39.3 billion (Grand View Research, 2024). However, including a broader definition, the women's health technology ecosystem is worth nearly $60 billion (Statista, 2024), depending on which fertility care, diagnostics, digital therapeutics, and wellness platforms are included.

A Shift in Women’s Healthcare Service Delivery: The expansion of this model reflects an essential change in the way healthcare is delivered, i.e., continuous monitoring, data-driven diagnostics, and preventive health systems are taking the place of episodic clinical interventions. Femtech platforms today cover menstrual tracking, fertility prediction, chronic disease monitoring, maternal care, and menopause management. In this way, they are creating almost a digital layer of healthcare services.

Growing Digital Infrastructure Enabling Femtech Industry’s Scale

Femtech has been growing rapidly over the past decade, and this growth can also be attributed to the emergence and development of the digital ecosystem. More specifically, increased access to healthcare via mobile devices around the world has contributed to femtech’s growth. According to the OECD, about 89% of the population in the European Union aged 16 to 74 years access the internet using their smartphones.

The mobility-driven ecosystem has made it possible for femtech startups to overcome various traditional limitations related to healthcare services, such as the lack of access to clinical facilities, geographical barriers, and delayed medical appointments. Thus, these technologies have become capable of providing an extensive list of health services directly to customers, including menstrual cycle monitoring, fertility prediction applications, telemedicine consultations, and continuous monitoring of various chronic conditions.

AI Technology Development Powering Femtech’s Growth

Further development of artificial intelligence technology continues to enhance and expedite these trends within the femtech industry. A Grand View Research report concludes that one of the key drivers behind the femtech market’s growth at a 16.4% CAGR is the increasing adoption of AI technologies. The market today has a broad range of applications for AI technologies, including predicting infertility, optimizing IVF cycles, assessing maternal risks, and disease detection systems.

A Funding Ecosystem Defined by Structural Inequality

Despite the growth experienced by femtech, there exist several challenges in capital allocation to femtech players. As stated by Galen Growth, the collective venture capital invested in femtech companies amounted to around $2.2 billion in 2024. Although this statistic may indicate the rising popularity of femtech and its impending potential, the amount of money spent on the problem is rather insignificant considering the scope of global healthcare service problems.

According to a McKinsey analysis of venture capital inflows into digital health, femtech comprises a mere 3% of the overall investment made in the industry. What makes this statistic more notable is the fact that the industry is designed to target health issues that impact about half of the world’s population, yet its total investment share remains meagre.

The lack of adequate investment is not confined to early-stage companies and impacts the whole value chain of healthcare.

Femtech’s Future: A Market Transitioning Through Lifecycle Health Demands

The development of femtech in the future will be more about lifecycle-driven healthcare solutions as opposed to segmented healthcare products based on their type. The focus is now shifting from condition-specific care or standalone tools to lifecycle-driven solutions that address women's varied needs at different points in their lives.

In such an emerging scenario, menopause can easily be considered one of the most important and fastest-growing sectors in terms of healthcare needs. It is estimated that around 1.2 billion women worldwide will either be going through menopause or have gone through it by the year 2030, making it one of the most underserved sections in healthcare all across the globe.

Key Femtech Growth Areas and Unmet Health Needs: Fertility technology is one of the more mature sub-segments in femtech owing to the sheer frequency of infertility that affects one out of six individuals worldwide, as reported by the World Health Organization (WHO). The high incidence of infertility has been a major contributor to the rapid advances in innovations like optimizing in-vitro fertilization, sophisticated hormonal monitoring devices, and AI-enabled technologies.

On the other hand, key diseases affecting the health of millions of women worldwide are still not being diagnosed properly. This serves as a powerful motivation for innovations in this field. There is a growing need for better diagnostic methods, monitoring, and a more personal approach to the provision of healthcare services for women, and innovators who focus on unmet needs will stand to grow.

Femtech Concerns: Privacy, Ethics, and the Trust Barrier

With the increasing data-driven nature of femtech, issues pertaining to privacy and the ethical use of data have become key considerations when looking at scaling up femtech in the future. A digital health security review conducted in 2024 identified that most femtech applications show vulnerabilities consistent with the OWASP Top 10 cybersecurity threats, posing problems for the safe handling of very sensitive reproductive health data.

In contrast to conventional health apps, femtech applications deal with extremely private details like menstrual cycles, fertility goals, pregnancy status, hormonal changes, and sexual health markers.

The Future of Femtech

Femtech has been identified as the key pillar for the future of global healthcare systems because of its predicted value of $97.3 billion by 2030, existing financing gaps, and massive unmet medical needs. The femtech movement is an intersection of artificial intelligence, digital health architecture, and traditional gender imbalances in medical research and investment.

In the long run, the success of femtech will be determined by how well healthcare systems can combine capital, clinical research, and innovation to address women’s medical needs. Otherwise, femtech will no longer be seen as just a sub-segment of digital health; it will evolve into a defining element of digital health.